Zusduri Kit
Product Images NDC 72493-106

Product Visual Gallery

This gallery contains 43 technical images submitted to the FDA as part of the official labeling for Zusduri (NDC 72493-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Urogen Pharma, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zusduri 01)

Chemical structure of mitomycin shown as a two-dimensional molecular diagram, highlighting its functional groups and ring system typical of the antibiotic antineoplastic agent.*

FDA Label Image

Image (Zusduri 02)

ZUSDURI kit by UroGen Pharma, Inc., shown open, revealing three vials inside. Each vial is paired with a labeled insert or document below the box with abbreviations PI, IFP, and IFA. The image depicts the packaging configuration of the Mitomycin drug kit.*

FDA Label Image

Image (Zusduri 03)

An illustration showing two syringes marked with volume measurements up to 20 mL. The syringes have plungers and nozzle tips, depicted in a simple black and white line drawing style.*

FDA Label Image

Image (Zusduri 04)

The image shows two syringes labeled with graduation markings from 0 to 4 milliliters. Both syringes have a clear barrel with black measurement lines and a plunger. The syringes are depicted horizontally, one above the other, without any additional packaging or labels visible. This image represents components of the ZUSDURI Mitomycin kit by UroGen Pharma.*

FDA Label Image

Image (Zusduri 05)

An instructional illustration showing three angled views of a medical dosing device or applicator, each view depicting measurement markings on the side. The device appears to be used for precise liquid measurement or administration, likely relating to the ZUSDURI (Mitomycin) kit by UroGen Pharma, Inc.*

FDA Label Image

Image (Zusduri 06)

An instructional illustration showing four sequential steps for preparing or handling a medical vial with a stopper and cap mechanism. Each image depicts the vial and the process of removing or manipulating the stopper and cap, commonly used in drug administration kits like ZUSDURI Mitomycin Kit.*

FDA Label Image

Image (Zusduri 07)

An illustrated diagram of a ZUSDURI kit container showing labeled compartments for syringes, vials, and a vial. The container is white and features the UroGen Pharma logo in blue on the front.*

FDA Label Image

Image (Zusduri 08)

Illustration showing a medical kit container labeled with the UroGen Pharma logo. The container has two syringes fitted in place and one labeled 'Not in Use,' indicating its purpose for organizing or preparing medication components, likely related to the ZUSDURI kit by UroGen Pharma, Inc.*

FDA Label Image

Image (Zusduri 09)

FDA Label Image

Image (Zusduri 10)

An instructional illustration showing a vial with a stopper and an applicator device containing a chamber and a plunger, likely used together for medication preparation or administration in a kit format.*

FDA Label Image

Image (Zusduri 11)

An instructional illustration depicting a two-part assembly process of a kit component, likely related to ZUSDURI. The image shows a top part with angled extensions above a cylindrical piece with a threaded section, suggesting attachment or connection steps.*

FDA Label Image

Figure 1 (Zusduri 12)

An instructional diagram illustrating the attachment process of a component to a larger device or container, showing a top piece aligning and connecting onto a bottom piece with directional arrows indicating movement.*

FDA Label Image

Image (Zusduri 13)

An instructional illustration showing a hand gripping the top part of an assembly, with arrows indicating actions applied to the sides of a component. The image suggests a step in preparing or using the ZUSDURI Kit involving manipulation of the device parts for assembly or activation.*

FDA Label Image

Figure 1 (Zusduri 14)

An illustration showing a hand holding a vial with a cap being twisted or removed, indicated by a circular arrow around the vial's base. The vial has a blank label and appears to be part of an instructional diagram, likely related to preparation or usage steps.*

FDA Label Image

Image (Zusduri 15)

FDA Label Image

Figure 1 (Zusduri 16)

ZUSDURI (Mitomycin) prescription drug kit with a brown vial featuring a white label and a white cap. The vial is intended for pharmaceutical use as supplied by UroGen Pharma, Inc.*

FDA Label Image

Image (Zusduri 17)

An illustration depicting a container filled with multiple small, irregularly shaped white objects, resembling ice cubes or crystalline substances. The image is simple, with a gray container and white contents, presented on a plain white background.*

FDA Label Image

Image (Zusduri 18)

ZUSDURI kit by UroGen Pharma, Inc. The image shows a simple, clear resealable plastic pouch with a zipper lock at the top. No additional labeling or printed information is visible on the pouch itself.*

FDA Label Image

Image (Zusduri 19)

An instructional illustration showing a circular medical device component with a locking mechanism and an attached small clip, likely part of a kit. The image is simple and line-drawn without text, showing the shape and key features of the device.*

FDA Label Image

Image (Zusduri 20)

ZUSDURI kit containing Mitomycin, a human prescription drug by UroGen Pharma, Inc. The packaging features a predominantly white kit with blue accents and includes multiple components inside. The label shows the brand name, active ingredient Mitomycin, and NDC 72493-106.*

FDA Label Image

Image (Zusduri 21)

ZUSDURI kit by UroGen Pharma, Inc featuring a medical device component part with a white cap and ribbed section designed for connection. The image shows a close-up of the device included in the kit, likely used for preparation or delivery of the mitomycin drug.*

FDA Label Image

Image (Zusduri 22)

ZUSDURI kit by UroGen Pharma, Inc consists of two vials: a clear vial labeled as Mitomycin powder and a blue vial labeled as diluent or solvent. The packaging indicates it is intended for human prescription use. The vials are displayed side by side against a white background with the labeler and product name clearly visible.*

FDA Label Image

Image (Zusduri 23)

Image shows four clear plastic syringes, each with black measurement markings in milliliters (mL) from 0 to 20 mL. The syringes have a plunger and a needle attachment tip. This image likely represents components of the ZUSDURI (Mitomycin) kit by UroGen Pharma, Inc.*

FDA Label Image

Image (Zusduri 24)

ZUSDURI kit packaging by UroGen Pharma, Inc. The label indicates the product contains Mitomycin as the active ingredient. The package includes essential details such as manufacturer information, product usage instructions, and regulatory compliance icons. The design is primarily white with purple and black text elements.*

FDA Label Image

Image (Zusduri 25)

An illustration of a syringe marked with volume measurements from 1 mL to 5 mL. The syringe is depicted upright with a plunger and needle hub visible, but no needle attached.*

FDA Label Image

Image (Zusduri 26)

An illustration showing five syringe-like vials with caps, aligned side-by-side. The vials appear to be part of a kit, possibly for medication administration, representing components typically included in a prescription drug kit.*

FDA Label Image

Image (Zusduri 27)

ZUSDURI Mitomycin Kit packaging label from UroGen Pharma, Inc. The box is predominantly white with blue and gray text and accents. It prominently features the proprietary name ZUSDURI and the generic name Mitomycin. The label includes the National Drug Code (NDC) 72493-106 and indicates it is a human prescription drug presented in kit form. The design includes a blue geometric shape near the top left and additional text detailing product information.*

FDA Label Image

Image (Zusduri 28)

An instructional illustration showing a vial placed in a container filled with ice, alongside a timer graphic displaying 20 minutes, indicating a cooling or chilling step likely required for preparation or storage.*

FDA Label Image

Image (Zusduri 29)

An instructional illustration showing multiple syringes placed in a container filled with ice, alongside a clock icon indicating a 2-minute duration. This image suggests a step involving cooling or chilling of syringes as part of preparation or handling instructions.*

FDA Label Image

Image (Zusduri 30)

ZUSDURI kit by UroGen Pharma, Inc, labeled with the proprietary name and generic name Mitomycin. The carton-style packaging is white with an orange and yellow curved design pattern. The NDC 72493-106 is visible on the side panel along with storage and manufacturer information. The kit format is indicated but no specific dosage or count is visible.*

FDA Label Image

Image (Zusduri 31)

An instructional illustration showing a syringe connected to an IV line with a 30-second timer icon nearby, likely indicating the duration for an infusion or injection step.*

FDA Label Image

Image (Zusduri 32)

Illustration of a clock face indicating a 15-minute time interval, commonly used to represent duration or timing instructions.*

FDA Label Image

Image (Zusduri 33)

An illustration showing two components of a kit, likely parts of a connectable medical device or syringe assembly. The top component has a locking mechanism, and the bottom component is a cylindrical connector or vial adapter. There is no text or branding visible in the image.*

FDA Label Image

Image (Zusduri 34)

An instructional diagram illustrating how to attach a component to a gas cylinder or similar container. The image shows a connector piece aligned above a cylindrical container with an arrow indicating the direction to secure or press the components together.*

FDA Label Image

Image (Zusduri 35)

An instructional illustration showing a hand gripping the top part of a vial labeled with two arrows pointing in opposite directions, indicating a step in preparing or connecting the vial. The image is black and white line art and appears to be part of a medication preparation kit.*

FDA Label Image

Image (Zusduri 36)

Illustration showing two small trays filled with ice. The upper tray holds one vial upright, while the lower tray contains multiple syringes upright among the ice. The image suggests storage or preparation of injectable medication components on ice.*

FDA Label Image

Image (Zusduri 37)

An instructional line drawing showing two hands connecting or assembling parts of a medical device or kit component. The left hand holds a cylindrical item, while the right hand holds a cap or connector piece. Above, a small separate part is depicted, indicating it is about to be attached or used in the assembly.*

FDA Label Image

Image (Zusduri 38)

An instructional illustration showing hands connecting or disconnecting two parts of a medical device, likely a syringe or similar administering component. An arrow indicates the direction for attaching or detaching the connection.*

FDA Label Image

Image (Zusduri 39)

An instructional illustration showing the use of a dropper or syringe to connect or administer medication, as indicated by the hands manipulating the device and an arrow pointing directionally from left to right.*

FDA Label Image

Principal Display Panel (40 mg Kit Carton)

Packaging label for ZUSDURI (mitomycin) single-dose kit for intravesical solution, 40 mg per vial by UroGen Pharma, Inc. The kit includes 2 single-dose vials of ZUSDURI, 1 single-dose vial of sterile hydrogel (60 mL), an admixture label, full prescribing information, and instructions. Warning indicates use for intravesical only with storage and reconstitution instructions noted.*

FDA Label Image

Principal Display Panel (40 mg Vial Label)

Label for Zusduri (mitomycin) intravesical solution, 40 mg per vial, single-dose sterile vial. Contains usage warnings, storage instructions between 20°C to 25°C, and preparation note to reconstitute with sterile hydrogel. Manufactured and distributed by UroGen Pharma, Inc, Princeton, NJ. Label includes lot and expiration date fields and barcode.*

FDA Label Image

Principal Display Panel (60 mL Vial Label)

Sterile Hydrogel single-dose vial label for use in preparation of ZUSDURI (mitomycin) intravesical solution. The 60 mL vial is distributed by UroGen Pharma, Inc. The label includes storage instructions and a barcode, noting the product is for pharmacy preparation only and not for direct administration.*

FDA Label Image

Image (Zusduri 43)

ZUSDURI Kit containing Mitomycin presented in a blister pack. The label shows the product name ZUSDURI along with the UroGen Pharma, Inc labeler information. The blister pack includes multiple dosage compartments clearly visible through the packaging film.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.